Detalhe da pesquisa
1.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021929
2.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779595
3.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443559
4.
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Br J Haematol
; 194(1): 145-157, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34124796
5.
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1875-1883, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085303
6.
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1029-1034, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369800
7.
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.
Cancer Discov
; : OF1-OF14, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583184
8.
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
Transplant Cell Ther
; 29(7): 465.e1-465.e7, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003415
9.
promor: a comprehensive R package for label-free proteomics data analysis and predictive modeling.
Bioinform Adv
; 3(1): vbad025, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922981
10.
Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide.
Leuk Res Rep
; 20: 100388, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37701906
11.
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.
Leukemia
; 37(5): 1006-1017, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310182
12.
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
Blood Adv
; 7(12): 2746-2757, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827681
13.
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Blood Adv
; 7(22): 7007-7016, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792849
14.
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome.
Transplant Cell Ther
; 28(1): 48.e1-48.e10, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587551
15.
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 28(6): 310-320, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314376
16.
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Blood Adv
; 6(1): 339-357, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547770
17.
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
JAMA Oncol
; 8(3): 404-411, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35024768
18.
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Transplant Cell Ther
; 28(4): 187.e1-187.e10, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081472
19.
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
Transplant Cell Ther
; 28(10): 681-693, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853610
20.
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden.
Transplant Cell Ther
; 27(3): 264.e1-264.e7, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781533